Health and Life Science Law Society (HaLS): “Ketamine, MDMA, and Psilocybin: How Psychedelics are Moving Towards FDA Approval ” – Vincent Joralemon
Wednesday, November 5, 2025 @ 1:00 pm - 2:00 pm
Event Navigation
Health and Life Science Law Society (HaLS) is a student organization at at Berkeley Law dedicated to supporting students interested in biotechnology law, health policy, and related areas in the life sciences. We host guest speaker events, networking opportunities, and mentorship programs while fostering a strong community for anyone exploring these fields. All students are welcome to join!
Please join us on November 5th, 2025, at 1-2pm in Room 170 for a discussion with Vincent Joralemon on “Ketamine, MDMA, and Psilocybin: How Psychedelics are Moving Towards FDA Approval.”
“Psychedelic therapies are inching from prohibition toward mainstream care, but access turns on three gates: FDA approval, DEA rescheduling, and insurance reimbursement. This talk, hosted by the new Life Sciences Law & Policy Center Director Vincent Joralemon, will trace how those gates actually open, using ketamine, MDMA, and psilocybin as case studies. No prior knowledge (or experience) necessary—we’ll provide all of the background you need.”
Please RSVP here by EOD Monday, November 3rd, 2025. Lunch will be provided!
These events are open only to UC Berkeley Law students, faculty, and staff, unless otherwise noted.
Events are wheelchair accessible. For disability-related accommodations, contact the organizer of the event. Advance notice is kindly requested.
If you have any photos or video from your event that you’d like to share with Berkeley Law for possible use in our digital and print marketing, please email communications@law.berkeley.edu.
Interested in receiving a weekly email digest of Berkeley Law events? Subscribe here.